5-HT1A Receptors
The serotonin 5-HT1A receptor was the first 5-HT receptor to be fully sequenced and the human gene encoding this receptor has been localized on chromosome 5 (5q11.2-q13).
- IUPHAR Receptor code: 5-HT1A
- BJP Guide: 5-HT1A
5-HT1A Receptors - More Information
5-HT1A receptor binding sites are located primarily in limbic brain areas, notably the hypothalamus, lateral septum, cortical areas and the mesencephalic raphe nuclei. 5-HT1A receptor ligands with agonist activity possess antianxiety, antidepressant, antiaggressive, and perhaps anticraving, anticataleptic, antiemetic, and neuroprotective properties.
5-HT1A Receptor Gene Data
| Species | Gene Symbol | Gene Accession No. | Protein Accession No. |
|---|
| Human | HTR1A | NM_000524 | P08908 |
| Mouse | Htr1a | NM_008308 | Q64264 |
| Rat | Htr1a | NM_012585 | P19327 |
5-HT1A Receptor Products
Featured Products |
|
Cat.No. |
Product Name / Activity |
| 1080 | (R)-(+)-8-Hydroxy-DPAT hydrobromide |
| Selective 5-HT1A agonist. More active enantiomer of Cat. No. 0529 | |
| 0529 | 8-Hydroxy-DPAT hydrobromide |
| Selective 5-HT1A agonist. Also has moderate affinity for 5-HT7 | |
| 1253 | (S)-WAY 100135 dihydrochloride |
| Potent, selective 5-HT1A antagonist | |
Agonists |
|
Cat.No. |
Product Name / Activity |
| 1006 | BMY 7378 dihydrochloride |
| 5-HT1A partial agonist | |
| 0556 | BP 554 maleate |
| Selective 5-HT1A agonist | |
| 0962 | Buspirone hydrochloride |
| 5-HT1A partial agonist | |
| 1080 | (R)-(+)-8-Hydroxy-DPAT hydrobromide |
| Selective 5-HT1A agonist. More active enantiomer of Cat. No. 0529 | |
| 0529 | 8-Hydroxy-DPAT hydrobromide |
| Selective 5-HT1A agonist. Also has moderate affinity for 5-HT7 | |
| 0797 | 8-Hydroxy-PIPAT oxalate |
| High affinity 5-HT1A agonist | |
| 2399 | Indorenate hydrochloride |
| 5-HT1A, 5-HT1B and 5-HT2C agonist | |
| 1869 | Ipsapirone |
| Selective 5-HT1A agonist | |
| 0411 | MDL 73005EF hydrochloride |
| Potent and selective 5-HT1A partial agonist | |
| 1746 | Nemonapride |
| 5-HT1A agonist. Also highly potent D2-like dopamine antagonist | |
| 0912 | RU 24969 hemisuccinate |
| 5-HT1B/1A agonist | |
| 1771 | S 14506 hydrochloride |
| Highly potent 5-HT1A agonist; displays unique binding mechanism | |
| 2854 | Tandospirone hydrochloride |
| Selective 5-HT1A partial agonist | |
| 2739 | U 92016A |
| Selective 5-HT1A agonist | |
| 1772 | Urapidil hydrochloride |
| 5-HT1A agonist. Also α1-adrenoceptor antagonist | |
| 2491 | Xaliproden hydrochloride |
| Orally active, high affinity 5-HT1A agonist | |
Antagonists |
|
Cat.No. |
Product Name / Activity |
| 2806 | Alprenolol hydrochloride |
| 5-HT1A antagonist | |
| 3346 |
ATC 0175 hydrochloride |
| Partial 5-HT1A antagonist. Also 5-HT2B and MCH1 antagonist | |
| 0993 | Cyanopindolol hemifumarate |
| 5-HT1A/1B antagonist. Also β-adrenergic antagonist | |
| 0933 | MM 77 dihydrochloride |
| 5-HT1A (postsynaptic) antagonist | |
| 3282 |
NAD 299 |
| Selective, high affinity 5-HT1A receptor antagonist | |
| 0553 | NAN-190 hydrobromide |
| 5-HT1A antagonist | |
| 0994 | Pindolol |
| 5-HT1A/1B antagonist. Also β-adrenergic antagonist | |
| 1060 | (S)-(-)-Pindolol |
| 5-HT1A/1B antagonist. Also β-adrenergic antagonist. More active enantiomer of Cat. No. 0994 | |
| 1516 | SDZ 21009 |
| 5-HT1A/1B antagonist. Also β-adrenoceptor antagonist | |
| 0631 | Spiroxatrine |
| 5-HT1A antagonist | |
| 1253 | (S)-WAY 100135 dihydrochloride |
| Potent, selective 5-HT1A antagonist | |
Other |
|
Cat.No. |
Product Name / Activity |
| 0412 | MDL 72832 hydrochloride |
| Potent 5-HT1A ligand | |
| 0581 | 3-MPPI |
| 5-HT1A ligand | |
Related Categories
Buy Now / Print Quote
Find multiple products by catalog number
Print Quote Facility
Order via your purchasing department
It's now even easier to place orders via your purchasing department.
Simply add a product to your cart & click on the "Print Quote" button.
GPCRs and Signalling Networks
Written by M.J. Marinissen
'G-Protein-coupled Receptors and Signalling Networks' summarizes the intricate network of intracellular signalling pathways involved in GPCR function.
Neurobiology of Parkinson's Disease
Written by A. Schapira
'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and highlights current and novel therapeutic interventions.
7-TM Receptor Signalling
Written by T. Kenakin et al
'Seven Transmembrane Receptor Signalling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy
Antidepressants - Current and Future Targets
Written by P. Skolnich et al
'Antidepressants - Current and Future Targets' provides an overview of the current and future targets for the treatment of major depressive disorder.
Tocris Events
Meet your representative
2nd UK Purine Symposium
September 17th, 2010
University of Nottingham